Clinical Trials on Difficult Intravenous Access in Austria

Total 48 results

Medical University Innsbruck

Completed

Different Techniques for Insertion of the ProSeal Laryngeal Mask Airway in Patients With Difficult Airway

Ventilation | Difficult Airway

Austria
The University of Queensland
Australasian Kidney Trials Network

Completed

Vascular Access Outcome Measure for Function: a vaLidation Study In haemoDialysis (VALID)

Vascular Access Complication | Hemodialysis Access Failure (Disorder)

Netherlands, Switzerland, Canada, France, United Kingdom, Australia, Malaysia
Becton, Dickinson and Company
Griffith University

Completed

Impact of PIVC Length and Gauge on Catheter Indwell Time

Indication for Peripheral Intravenous Catheterisation

Australia
Becton, Dickinson and Company

Completed

An Observational Study to Evaluate BD PureHub™ Disinfecting Cap Use on Needle-Free Connectors

Catheter Related Complication | Vascular Access Site Management | Disinfecting Cap

Belgium, Austria, Spain, Italy
Medical University of Graz

Completed

New Intubation Method to Achieve Circulatory Stability and to Reduce Number of Intubation Attempts in Neonates (NOONA)

Intubation; Difficult or Failed | Preterm Infant | Term Infant

Austria
Medical University of Vienna

Recruiting

Effect of Face Masks on Pulmonary Function in Patients With COPD

COPD | Walking, Difficulty

Austria
Children's Hospital of Philadelphia
Agency for Healthcare Research and Quality (AHRQ)

Recruiting

Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs (NEAR4KIDs)

Intubation Complication | Intubation; Difficult | Failed or Difficult Intubation, Sequela

United States, Canada, Japan, Italy, New Zealand, Singapore, Australia, Austria, Germany, India, United Kingdom
Menzies School of Health Research
Charles Darwin University; Northern Territory of Australia as represented by... and other collaborators

Recruiting

The Communicate Study Partnership

Aboriginal Health | Cultural Safety | Access to Interpreters | Healthcare Provider Training

Australia
The University of Queensland

Terminated

Using Lignocaine Spray and Gel to Reduce the Pain Associated With Nasogastric Tube Insertion in Children (NGTIPPS)

Intubation; Difficult

Australia
IRCCS San Raffaele

Completed

SUrgical Versus PERcutaneous AXillary Artery International Registry

Surgical and the Percutaneous Approach to the Upper Extremity Access

Spain, Sweden, Austria, Belgium, Germany, Switzerland, Italy, United States, France, United Kingdom
Macfarlane Burnet Institute for Medical Research...
St Vincent's Hospital Melbourne

Unknown

The TAP Study: Treating People Who Inject Drugs in Community-Based Settings Using a Social Network Approach (TAP)

Hepatitis C | Drug Abuse, Intravenous

Australia
Schulthess Klinik

Completed

The i-GelTM. A Randomized, Crossover Study With the Laryngeal Mask Airway ProSealTM in Anesthetized Pediatric Patients

Device Success Rate | Device Performance

Switzerland, Austria
Singapore General Hospital

Recruiting

A Prospective, Randomized Controlled Trial of Stent Graft and Drug Coated Balloon Treatment for Recurrent Cephalic Arch Stenosis in Dysfunctional Arteriovenous-venous Fistula (PREDATOR)

Dialysis Access Malfunction | Neointimal Hyperplasia

Singapore, Australia
Medical University of Vienna

Completed

Oxygen Insuflation and ArterialDesaturation During Tracheal Intubation in Children

Difficult Airway | Infants

Austria
Medical University of Vienna

Completed

Plasma and Abscess Fluid Pharmacokinetics of Cefpirome and Moxifloxacin After Single and Multiple Dose Administration

Cysts | Abscess

Austria
Biotronik AG

Completed

BIOTRONIK 4French for AMBulatory Peripheral Intervention (BIO4AMB)

Peripheral Artery Disease | Access Site Complication | Outpatient Treatment

France, Austria, Belgium, Switzerland
SurModics, Inc.

Active, not recruiting

Safety and Efficacy of the SurVeil™ Drug-Coated Balloon (AVess FIH)

Hemodialysis Access Failure

Australia, New Zealand
Astellas Pharma Europe Ltd.
Cubist Pharmaceuticals LLC

Terminated

A Post-marketing, Blinded Study to Investigate How Effective Fidaxomicin is Compared to Vancomycin in the Sustained Cure of Clostridium Difficile Infection in Adults That Are Receiving Therapy to Suppress the Immune System (FREEDOM)

Clostridium Difficile

Spain, France, Germany, Greece, Denmark, Austria, Poland
Valneva Austria GmbH

Completed

An Open-label Study Assessing Safety, Immunogenicity and Dose Response of IC84

Clostridium Difficile Infection

Austria, Hungary
Seton Healthcare Family
Scientific, Education and Research Foundation of UTSW Austin

Completed

Comparison of Loop Drainage Versus Incision and Drainage for Abscesses in Children

Abscess of Skin and/or Subcutaneous Tissue

United States
Novartis Pharmaceuticals
University of Pennsylvania

Recruiting

CAR-T Long Term Follow Up (LTFU) Study (PAVO)

Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program

United States, Japan, Australia, Germany, Spain, Belgium, Taiwan, Italy, Canada, Israel, Singapore, United Kingdom, Denmark, Finland, Norway, Austria, Netherlands, France
Children's Hospital of Philadelphia
Baylor College of Medicine; Children's Hospital Colorado; Seattle Children's... and other collaborators

Recruiting

Nasotracheal Intubation With VL vs DL in Infants Trial (NasoVISI)

Hypoxia | Intubation Complication | Intubation; Difficult or Failed | Hypoxemia | Anesthesia Intubation Complication | Pediatric HD

United States
Pfizer

Recruiting

To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons. It Will Be Given Twice Over a Period of Time to Healthy Adults

Clostridoides Difficile Associated Disease

United States
Pfizer

Completed

A Study To Investigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 to 85 Years, Who Will Each Receive 3 Doses Of Vaccine.

Clostridium Difficile Associated Disease

United States
Pfizer

Completed

A Study To Investigate Two 3-dose Schedules Of A Clostridium Difficile Vaccine In Healthy Adults Aged 65 to 85 Years

Clostridium Difficile Associated Disease

United States
Astellas Pharma Europe Ltd.

Completed

Study to Evaluate the Pharmacokinetics of Fidaxomicin in Inflammatory Bowel Disease (IBD) Subjects With Clostridium Difficile Infection (CDI) (PROFILE)

Inflammatory Bowel Disease (IBD) | Clostridium Difficile Infection (CDI)

Austria, France, Greece, Italy, Poland, Russian Federation, United Kingdom
Pfizer

Completed

Evaluation Of Clostridium Difficile Vaccine Lot Consistency In Healthy Adults 65 To 85 Years Of Age

Clostridium Difficile Associated Disease

United States
The Touro College and University System
University of Vienna; Osato Research Institute; University of Mauritius; Mauritius... and other collaborators

Completed

Molecular and Clinical Effects of Green Tea and Fermented Papaya Preparation on Diabetes and Cardiovascular Diseases

Assess the Effect of Green Tea on Diabetes | Assess the Effect of Fermented Papaya Pretration on Diabetes | Effects of Green Tea and FPP on C-reactive Proteins | Effects of Green Tea and FPP of Lipid Profiles in Diabetes | Effect of Green Tea and FPP on Atheroma Formation

Austria, Mauritius, United States
Pfizer

Completed

Clostridium Difficile Vaccine 2-Dose Versus 3-Dose Study

Clostridium Difficile Associated Disease

United States
Astellas Pharma Europe Ltd.
Merck Sharp & Dohme LLC

Completed

A Phase IIIB/IV Study to Compare the Efficacy of Vancomycin Therapy to Extended Duration of Fidaxomicin Therapy in the Clinical Cure of Clostridium Difficile Infection (CDI) in an Older Population (EXTEND)

Clostridium Difficile

Greece, Spain, Russian Federation, Denmark, Austria, Belgium, Croatia, Czechia, Finland, France, Germany, Hungary, Ireland, Italy, Poland, Portugal, Romania, Slovenia, Sweden, Switzerland, Turkey, United Kingdom
The University of Queensland
Queensland Children's Hospital; Griffith University; Royal Brisbane and Women... and other collaborators

Recruiting

Novel Antimicrobial Dressing in Peripheral Intravenous Catheters (PIVCs) (ProP)

Wound Infection | Catheter Infection | Catheter-Related Infections | Wound | Vascular Access Complication | Catheter Complications | Device Related Infection | Wound of Skin | Catheter Related Complication | Device Related Sepsis | Occlusive Dressings | Device Site Reactions

Australia, France
VenoStent

Recruiting

SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study (SAVE-FistulaS)

Chronic Kidney Diseases | Renal Insufficiency | Renal Failure | End Stage Renal Disease | Hemodialysis Access Failure | ESRD | Arteriovenous Fistula | Vascular Access Complication | Catheter Complications | Catheter Dysfunction

United States
Summit Therapeutics

Completed

Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection (Ri-CoDIFy 1)

Clostridioides Difficile Infection

United States, Australia, Greece, Canada, Spain, Brazil, Poland, Korea, Republic of, Argentina, Bulgaria, Hungary, New Zealand, Romania, Russian Federation
Onconova Therapeutics, Inc.

Completed

Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine

Myelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | Cytopenia | Refractory Anemia With Excess Blasts

United States, Australia, Spain, Italy, Germany, France, Sweden, Denmark
Summit Therapeutics

Completed

To Compare Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection (Ri-CoDIFy 2)

Clostridioides Difficile Infection

United States, Spain, France, Canada, Belgium, Israel, Chile, Belarus, Latvia, Germany, Romania, Lithuania, Mexico, Czechia, Estonia, Georgia, Peru
C. R. Bard

Terminated

SHERLOCK 3CG™ Diamond Tip Confirmation System (MODUS II)

Bundle-Branch Block | Tachycardia | Atrioventricular Block | Atrial Flutter | Premature Ventricular Contraction | Premature Atrial Contraction | Indication for Peripheral Intravenous Catheterization | Premature Junctional Contraction

United States, Australia
Onconova Therapeutics, Inc.

Terminated

Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA (INSPIRE)

Myelodysplastic Syndrome | MDS | Refractory Anemia With Excess Blasts | RAEB

United States, Spain, Canada, France, Australia, Switzerland, Israel, Japan, Belgium, India, Ireland, United Kingdom, Croatia, Czechia, Poland, Estonia, Germany, Italy, Austria, Hungary, Russian Federation, Sweden
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)

Cholecystitis | Appendicitis | Diverticulitis | Intra-Abdominal Abscess | Intra-Abdominal Infection | Peritonitis

Italy, Spain, China, France, Switzerland, Australia, Denmark, Finland, Germany, Greece, Hong Kong, India, Philippines, Portugal, Saudi Arabia, South Africa, Taiwan, Turkey, United Kingdom
Stichting Hemato-Oncologie voor Volwassenen Nederland
Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)

Recruiting

A Study of Ivosidenib or Enasidenib in Combination With Induction Therapy and Consolidation Therapy, Followed by Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myedysplastic Syndrome EB2, With an IDH1 or IDH2 Mutation, Respectively, Eligible for Intensive Chemotherapy (HOVON150AML)

Acute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2

Australia, Austria, Belgium, Estonia, Finland, France, Germany, Ireland, Lithuania, Luxembourg, Netherlands, Norway, Spain, Sweden, Switzerland
Stichting Hemato-Oncologie voor Volwassenen Nederland
Astellas Pharma Global Development, Inc.; Deutsch-Österreichische Studiengruppe...

Active, not recruiting

A Study of Gilteritinib Versus Midostaurin in Combination With Induction and Consolidation Therapy Followed by One-year Maintenance in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndromes With Excess Blasts-2 With FLT3 Mutations Eligible for Intensive Chemotherapy (HOVON 156 AML)

Acute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2

Netherlands, Belgium, Germany, Switzerland, Australia, Finland, Norway, Sweden, Austria, France, Ireland, Lithuania, Luxembourg, Spain
Pfizer

Completed

Clostridium Difficile Vaccine Efficacy Trial (Clover)

Clostridium Difficile Infection

United States, Spain, Belgium, Taiwan, Japan, Portugal, Colombia, Korea, Republic of, Poland, Australia, Germany, Canada, Argentina, Bulgaria, Chile, Czechia, Finland, France, Hungary, Peru, Slovakia, Sweden, United Kingdom
Actelion

Completed

Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile - Associated Diarrhea

Clostridium Difficile Infection

United States, Australia, Brazil, Canada, France, Germany, Italy, Netherlands, Peru, Poland, Romania, Spain
Sanofi Pasteur, a Sanofi Company

Terminated

Study of a Candidate Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection

Clostridium Difficile Infection

Sweden, United States, Mexico, Philippines, Singapore, Germany, France, Canada, Australia, Peru, Colombia, Brazil, Costa Rica, Denmark, Dominican Republic, Finland, Guatemala, Japan, Korea, Republic of, Panama, Poland, Puerto Rico, ... and more
Infectopharm Arzneimittel GmbH
INPADS GmbH; Dr. Oestreich + Partner GmbH

Recruiting

Fosfomycin i.v. for Treatment of Severely Infected Patients (FORTRESS)

Respiratory Tract Infections | Sepsis | Encephalitis | Bacterial Infections | Intraabdominal Infections | Bacteremia | Skin Diseases, Bacterial | Pneumonia, Bacterial | Urinary Tract Infections | Meningitis, Bacterial | Central Nervous System Bacterial Infections | Soft Tissue Infections | Endocarditis, Bacterial | Bone Diseases, Infectious and other conditions

Germany, Austria, Greece, Italy, United Kingdom
University of Ulm

Recruiting

Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms, and Higher Risk Myelodysplastic Syndrome - The Biology and Outcome (BiO)-Project (AMLSG BiO)

Acute Myeloid Leukemia (AML) | Higher Risk Myelodysplastic Syndromes (MDS With Excess Blasts 2)

Austria, Germany
Durata Therapeutics Inc., an affiliate of Allergan...

Completed

Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Abscess | Cellulitis | Surgical Site Infection | Wound Infection

United States, Bulgaria, Estonia, Hungary, Israel, Korea, Republic of, Latvia, Lithuania, Romania, Russian Federation, Slovakia, South Africa, Taiwan, Ukraine
Targanta Therapeutics Corporation

Completed

A Study for Patients With Complicated Skin and Skin Structure Infections (SIMPLIFI)

Wounds and Injuries | Streptococcal Infections | Abscess | Cellulitis | Staphylococcal Skin Infections

United States, Australia, India, Italy, Romania, Ukraine
Bayer

Completed

Comparison of Sequential IV/PO Moxifloxacin With IV Piperacillin/Tazobactam Followed by PO Amoxicillin/Clavulanic Acid in Patients With a Complicated Skin and Skin Structure Infection

Diabetic Foot | Ulcer | Abscess | Wound Infection

Italy, Spain, Greece, Ireland, Russian Federation, United Kingdom, Germany, Austria, Belgium, France, Hungary, South Africa, Romania, Bulgaria, Poland, Israel, Latvia, Ukraine, Lithuania, Netherlands

Clinical Trials on Difficult Intravenous Access in Austria

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Colombia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations